Clinical Trial Update: PD-1 Inhibition in Advanced Myeloproliferative Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 trial assessing PD-1 inhibition in advanced myeloproliferative neoplasms has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Phase Myelofibrosis
• Polycythemia Vera
• Post-essential Thrombocythemia Myelofibrosis

Snippet

Sponsor: John Mascarenhas | Conditions: Chronic Phase Myelofibrosis, Primary Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-21